74 related articles for article (PubMed ID: 21564031)
1. Botulinum toxin type A for treatment of dyspareunia caused by localized scleroderma.
Mousty E; Rathat G; Rouleau C; Giacalone PL
Acta Obstet Gynecol Scand; 2011 Aug; 90(8):926-7. PubMed ID: 21564031
[No Abstract] [Full Text] [Related]
2. Successful treatment of vulvodynia with botulinum toxin A.
Tieu KD; MacGregor JL
Arch Dermatol; 2011 Feb; 147(2):251-2. PubMed ID: 21339463
[No Abstract] [Full Text] [Related]
3. Improvement of "En Coup de Sabre" Morphea and Associated Headaches With Botulinum Toxin Injections.
Rimoin L; Arbiser J
Dermatol Surg; 2016 Oct; 42(10):1216-9. PubMed ID: 27465255
[No Abstract] [Full Text] [Related]
4. Successful use of botulinum toxin type a in the treatment of refractory postoperative dyspareunia.
Park AJ; Paraiso MFR
Obstet Gynecol; 2009 Aug; 114(2 Pt 2):484-487. PubMed ID: 19622971
[TBL] [Abstract][Full Text] [Related]
5. Multiple eccrine hidrocystomas treated with botulinum toxin A.
Kontochristopoulos G; Markantoni V; Stefanaki C; Kanelleas A; Rigopoulos D; Gregoriou S
Clin Exp Dermatol; 2011 Jan; 36(1):95-6. PubMed ID: 20184610
[No Abstract] [Full Text] [Related]
6. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.
Chankrachang S; Arayawichanont A; Poungvarin N; Nidhinandana S; Boonkongchuen P; Towanabut S; Sithinamsuwan P; Kongsaengdao S
Headache; 2011 Jan; 51(1):52-63. PubMed ID: 21083558
[TBL] [Abstract][Full Text] [Related]
7. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.
Bohluli B; Motamedi MH; Bagheri SC; Bayat M; Lassemi E; Navi F; Moharamnejad N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):47-50. PubMed ID: 20674409
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intra-articular injection of botulinum toxin type A in refractory hemiplegic shoulder pain.
Castiglione A; Bagnato S; Boccagni C; Romano MC; Galardi G
Arch Phys Med Rehabil; 2011 Jul; 92(7):1034-7. PubMed ID: 21704782
[TBL] [Abstract][Full Text] [Related]
9. Botulinum Toxin A in bruxers. One year experience.
Redaelli A
Saudi Med J; 2011 Feb; 32(2):156-8. PubMed ID: 21301762
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a pilot study.
Safarpour D; Salardini A; Richardson D; Jabbari B
Pain Med; 2010 Sep; 11(9):1411-4. PubMed ID: 20609130
[TBL] [Abstract][Full Text] [Related]
11. Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment.
Mouttalib S; Khan S; Castel-Lacanal E; Guillotreau J; De Boissezon X; Malavaud B; Marque P; Rischmann P; Gamé X
BJU Int; 2010 Dec; 106(11):1677-80. PubMed ID: 20590550
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A in the treatment of Raynaud's phenomenon.
Neumeister MW
J Hand Surg Am; 2010 Dec; 35(12):2085-92. PubMed ID: 21134617
[TBL] [Abstract][Full Text] [Related]
13. Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache.
Ahmed K; Oas KH; Mack KJ; Garza I
Pediatr Neurol; 2010 Nov; 43(5):316-9. PubMed ID: 20933173
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin A (Botox) for treatment of proximal myofascial pain in complex regional pain syndrome: two cases.
Safarpour D; Jabbari B
Pain Med; 2010 Sep; 11(9):1415-8. PubMed ID: 20735753
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A for Levodopa-induced cervical dyskinesias in Parkinson's disease: unfavorable risk-benefit ratio.
Espay AJ; Vaughan JE; Shukla R; Gartner M; Sahay A; Revilla FJ; Duker AP
Mov Disord; 2011 Apr; 26(5):913-4. PubMed ID: 21432906
[No Abstract] [Full Text] [Related]
16. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin for lower lid entropion correction.
Deka A; Saikia SP
Orbit; 2011 Jan; 30(1):40-2. PubMed ID: 21281080
[TBL] [Abstract][Full Text] [Related]
18. Study of botulinum toxin A in neurogenic bladder due to spina bifida in children.
Deshpande AV; Sampang R; Smith GH
ANZ J Surg; 2010 Apr; 80(4):250-3. PubMed ID: 20575951
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A for neuropathic itch.
Wallengren J; Bartosik J
Br J Dermatol; 2010 Aug; 163(2):424-6. PubMed ID: 20346021
[No Abstract] [Full Text] [Related]
20. Adverse events after botulinum A toxin injection for neurogenic voiding disorders.
De Laet K; Wyndaele JJ
Spinal Cord; 2005 Jul; 43(7):397-9. PubMed ID: 15741978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
